CDKN2A and glioblastoma: Work from the Van Lohuizen laboratory revealed that BMI1 is highly expressed in human GBM samples and that Bmi1 deficiency reduces the invasiveness of malignant mouse astrocytes carrying a null mutation in the Ink4a/Arf locus [91].